POSTMENOPAUSAL OSTEOPENIA

Clinical trials for POSTMENOPAUSAL OSTEOPENIA explained in plain language.

Never miss a new study

Get alerted when new POSTMENOPAUSAL OSTEOPENIA trials appear

Sign up with your email to follow new studies for POSTMENOPAUSAL OSTEOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New study tests alternative to prevent bone loss after stopping popular osteoporosis drug

Disease control Not yet recruiting

This study aims to find out if a drug called ibandronate works as well as the current standard drug, zoledronic acid, to protect bones after women stop taking denosumab for osteoporosis. It will involve 52 postmenopausal women who have taken denosumab for less than three years. R…

Matched conditions: POSTMENOPAUSAL OSTEOPENIA

Phase: PHASE4 • Sponsor: National Taiwan University Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

POSTMENOPAUSAL OSTEOPENIA

Get alerted when new POSTMENOPAUSAL OSTEOPENIA trials appear

New study tests alternative to prevent bone loss after stopping popular osteoporosis drug